Regeneron CEO says its monoclonal antibodies protect people from Covid for months

Source: CNBC

“Regeneron’s monoclonal antibodies grant months of protection from Covid-19 and could be administered to individuals whose immune systems aren’t shielded enough by vaccines, CEO Len Schleifer told CNBC’s ‘Squawk Box’ on Monday. Schleifer’s comments came after Regeneron released data that indicated its one-dose antibody cocktail cut the risk of catching the virus by nearly 82% for two to eight months. … Individuals with immunocompromised conditions could eventually receive Regeneron’s monoclonals up to every five or six months, ‘and they would be protected just as though they were vaccinated,’ Schleifer said. He said the treatment could be administered selectively to those at high risk for Covid complications and essential workers with concerns over immunizing. But Schleifer noted that he didn’t think Regeneron could produce enough antibodies at an affordable price to use them as widely as vaccines.” (11/08/21)